The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

Completed · Phase 3

Conditions studied: Diabetes, Diabetes Mellitus, Type 2

In brief

This trial is conducted in Europe and North America. The aim of this clinical trial is to assess and compare the effect of insulin detemir in combination with liraglutide and metformin versus liraglutide and metformin in subjects with type 2 diabetes. Subjects will continue their own pre-trial metformin treatment during the trial.

Key facts

Study ID

NCT00856986

Run by

Novo Nordisk A/S

People needed

987

Starts

2009-03-01

Expected to finish

2010-11-01

Last updated by the study team

2017-03-08

Who can join

Age: 18 and older, up to 84. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects diagnosed with type 2 diabetes, insulin naïve and treated with metformin as monotherapy for at least 3 months prior to screening, at a stable dose of at least 1500 mg/day or metformin (at least 1500 mg/day) and a sulfonylurea (less than or equal to half of the maximum approved dose), both at a stable dose for at least 3 months prior to screening. Previous short-term insulin treatment in connection with intercurrent illness is allowed at the discretion of the Investigator
• HbA1c 7.0-10.0% (both inclusive) for subjects on metformin monotherapy
• HbA1c 7.0-8.5% (both inclusive) for subjects on metformin in combination with a sulphonylurea

You may not qualify if…

• Previous treatment with insulin (except for short-term treatment in connection with intercurrent illness at the discretion of the Investigator)
• Treatment with glucose-lowering agent(s) other than stated in the inclusion criteria in a period of 3 months prior to screening
• Recurrent major hypoglycaemia or hypoglycaemic unawareness as judged by the Investigator
• Impaired kidney function
• Impaired liver function
• Uncontrolled treated/untreated hypertension
• Cancer or any clinically significant disease or disorder as judged by the Investigator
• Previous participation in the run-in phase of this trial. Re-screening is allowed once
• History of chronic pancreatitis or idiopathic pancreatitis

Where it is running

• Novo Nordisk Investigational Site — Birmingham, Alabama, United States
• Novo Nordisk Investigational Site — Encino, California, United States
• Novo Nordisk Investigational Site — Fullerton, California, United States
• Novo Nordisk Investigational Site — Inglewood, California, United States
• Novo Nordisk Investigational Site — La Jolla, California, United States
• Novo Nordisk Investigational Site — Los Gatos, California, United States
• Novo Nordisk Investigational Site — Montclair, California, United States
• Novo Nordisk Investigational Site — Spring Valley, California, United States
• Novo Nordisk Investigational Site — Tustin, California, United States
• Novo Nordisk Investigational Site — Walnut Creek, California, United States
• Novo Nordisk Investigational Site — Waterbury, Connecticut, United States
• Novo Nordisk Investigational Site — Bradenton, Florida, United States
• Novo Nordisk Investigational Site — Clearwater, Florida, United States
• Novo Nordisk Investigational Site — Jupiter, Florida, United States
• Novo Nordisk Investigational Site — Miami, Florida, United States
• Novo Nordisk Investigational Site — Miami, Florida, United States
• Novo Nordisk Investigational Site — Miami, Florida, United States
• Novo Nordisk Investigational Site — Atlanta, Georgia, United States
• Novo Nordisk Investigational Site — Decatur, Georgia, United States
• Novo Nordisk Investigational Site — Roswell, Georgia, United States
• Novo Nordisk Investigational Site — Savannah, Georgia, United States
• Novo Nordisk Investigational Site — Chicago, Illinois, United States
• Novo Nordisk Investigational Site — Quincy, Illinois, United States
• Novo Nordisk Investigational Site — Chicago Heights, Indiana, United States
• Novo Nordisk Investigational Site — Alexander City, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.